Search

Search Results

1. Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials

   Lung cancer is the leading cause of cancer-related death across the world. Unlike lung adenocarcinoma, patients with lung squamous cell carcinoma...

   Zhenyi Niu, Runsen **, ... Hecheng Li in Signal Transduction and Targeted Therapy

   Article Open access 05 October 2022
   

2. Basaloid Squamous Cell Carcinoma Cervix: A Case Report

   Basaloid squamous cell carcinoma (BSCC) is a very rare but aggressive subtype of squamous cervical cancer. BSCC usually arises from hypo pharynx,...

   Monika Dewan, S. B. L. Shrivastav, ... Amrita Singhal in Indian Journal of Gynecologic Oncology

   Article 07 January 2024
   

3. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma

   Pyroptosis-related long-noncoding RNAs (PRlncRNAs) play an important role in cancer progression. However, their role in lung squamous cell carcinoma...

   **ang Zhan, Jixian Li, ... Zhe Yang in Clinical and Experimental Medicine

   Article Open access 03 July 2024
   

4. Proposal of a grading system for squamous cell carcinoma of the lung — the prognostic importance of tumour budding, single cell invasion, and nuclear diameter

   The prognostic markers of lung squamous cell carcinoma (LSCC) are less investigated. The aim of our study was to evaluate tumour budding (TB),...

   Noémi Zombori-Tóth, Fanni Hegedűs, ... Tamás Zombori in Virchows Archiv

   Article Open access 09 August 2023
   

5. Acantholytic Squamous Cell Carcinoma: a Diagnostic Pitfall on Cytology

   Acantholytic squamous cell carcinoma is an infrequent subtype of squamous cell carcinoma. This tumour variant being rare in itself has been rarely...

   Md Ali Osama, Kavita Gaur, ... Divya Jyoti in Indian Journal of Surgical Oncology

   Article 12 September 2023
   

6. Primary pulmonary hyalinizing clear cell carcinoma with vocal-cord squamous cell carcinoma: a case report with systematic review

   Background

   Primary pulmonary hyalinizing clear cell carcinoma (HCCC) is a low-grade salivary gland-type carcinoma. Until now, 23 cases of pulmonary...

   Zhuo Li, Weihua Li, Liyan Xue in Diagnostic Pathology

   Article Open access 08 August 2023
   

7. FOXP3 expression in esophageal squamous cell carcinoma

   Objective

   Investigating the impact of FOXP3 (transcription factor forkhead box P3) expression on the biological behavior of esophageal squamous cell...

   Shenghong Wu, Yu Wang, ... Ming Ye in Wiener klinische Wochenschrift

   Article 24 October 2023
   

8. TET2 Is Downregulated in Early Esophageal Squamous Cell Carcinoma and Promotes Esophageal Squamous Cell Malignant Behaviors

   Objective

   To explore the expression of the ten eleven translocation (TET) 2 protein in early esophageal squamous cell carcinoma (EESCC), precancerous...

   Hui Wen, **ao-bo Liu, ... Sheng-bao Li in Digestive Diseases and Sciences

   Article 23 April 2024
   

9. Survival Outcomes of Non-squamous Cell Carcinoma and Rare Squamous Cell Carcinoma Variants of the Larynx

   The literature focuses primarily on laryngeal differentiated squamous cell carcinoma (SCC), and only a limited number of studies have evaluated the...

   Levent Yücel, Kadriye Bir Yücel, ... Zahide Çiler Büyükatalay in Indian Journal of Otolaryngology and Head & Neck Surgery

   Article 14 June 2023
   

10. Neuroendocrine differentiation distinguishes basaloid variant of lung squamous cell carcinoma

    Background

    Neuroendocrine (NE) differentiation is widely studied in non-small cell lung carcinomas (NSCLC) however, its significance remains unclear...

    Kianoosh Keyhanian, William J. Phillips, ... Harmanjatinder S. Sekhon in Diagnostic Pathology

    Article Open access 10 May 2022
    

11. Population-based high-dimensional analyses identify multiple intrinsic characters for cancer vaccines against lung squamous cell carcinoma

    In lung squamous cell carcinoma (LUSC), current cancer vaccines show promising effects, despite a lack of benefit for a large number of patients. We...

    Long** Zeng, Lingchen Li, ... Jianguo Sun in Medical Oncology

    Article 03 January 2024
    

12. Long-term survival after pulmonary metastasectomy in patients with esophageal squamous cell carcinoma with lung metastasis

    Objectives

    Esophageal squamous cell carcinoma with pulmonary metastasis has a poor prognosis, and the only treatment modality is systemic therapy such...

    Chien-Ming Lo, Kai-Hao Chuang, ... Shau-Hsuan Li in Journal of Cardiothoracic Surgery

    Article Open access 14 October 2022
    

13. ZEB1-activated Notch1 promotes circulating tumor cell migration and invasion in lung squamous cell carcinoma

    Background

    Lung squamous cell carcinoma (LUSC) is recognized as the major subtypes of non-small cell lung cancer (NSCLC). Circulating tumor cells...

    Yong Gao, **nyuan Cheng, Mingfeng Han in Clinical and Translational Oncology

    Article 23 November 2022
    

14. Establishment of a prognosis prediction model for lung squamous cell carcinoma related to PET/CT: basing on immunogenic cell death-related lncRNA

    Background

    Immunogenic cell death (ICD) stimulates adaptive immunity and holds significant promise in cancer therapy. Nevertheless, the influence of...

    Yu Han, Zhiqiang Dong, ... **aodong Wang in BMC Pulmonary Medicine

    Article Open access 15 December 2023
    

15. Breast Implant Capsule-Associated Squamous Cell Carcinoma: A Systematic Review and Case Presentation

    Abstract

    Breast implant capsule-associated squamous cell carcinoma is exceedingly rare, with only eleven previously published cases. The present study...

    Danniel Badri, Nicolas Copertino in Aesthetic Plastic Surgery

    Article Open access 05 October 2023
    

16. The relationship of airflow limitation with lung squamous cell carcinoma: evidence from mendelian randomization analysis

    Background

    Observational studies showed associations between smoking, and airflow limitation, with lung squamous cell carcinoma (LUSC). However, the...

    Qing Zhang, Guannan Cai, ... Ying Chen in Journal of Cancer Research and Clinical Oncology

    Article 28 February 2023

17. CISD2 promotes lung squamous carcinoma cell migration and invasion via the TGF-β1-induced Smad2/3 signaling pathway

    Background

    Although aberrant expression of CDGSH iron sulfur domain 2 (CISD2) contributes to the tumorigenesis and progression of numerous human...

    **g**g Zhang, Lifang Pan, ... Qiong Wu in Clinical and Translational Oncology

    Article 30 May 2023
    

18. Necitumumab plus gemcitabine and cisplatin in previously treated lung squamous cell carcinoma

    Background: The efficacy and safety of the anti-EGFR antibody necitumumab combined with gemcitabine and cisplatin (N + GC) in the first-line...

    Fumihiko Kinoshita, Yuka Oku, ... Tatsuro Okamoto in Investigational New Drugs

    Article 04 November 2022
    

19. Duodenal diverticulum metastasis from pulmonary squamous cell carcinoma diagnosed by EUS-FNA

    A 76-year-old male with pulmonary squamous cell carcinoma achieved complete response by chemoradiotherapy and subsequent systemic chemotherapy....

    Koji Sunaga, Teppei Yoshioka, ... Tetsuo Takehara in Clinical Journal of Gastroenterology

    Article 29 September 2022
    

20. Morphometric analysis of nuclear shape irregularity as a novel predictor of programmed death-ligand 1 expression in lung squamous cell carcinoma

    Immune checkpoint inhibitor (ICI) therapy has been established as one of the key treatment strategies for lung squamous cell carcinoma (LUSQ). The...

    Ryoko Saito-Koyama, Keiichi Tamai, ... Hironobu Sasano in Virchows Archiv

    Article 12 May 2023